Cue Biopharma, Inc.Cue Biopharma, Inc.Cue Biopharma, Inc.

Cue Biopharma, Inc.

No trades
See on Supercharts

Price target

3.600.000.00%
The 5 analysts offering 1 year price forecasts for CUE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to CUE in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CUE EPS for the last quarter is −0.17 USD despite the estimation of −0.18 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of Cue Biopharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Cue Biopharma, Inc. revenue is expected to reach ‪1.70 M‬ USD. Check out Cue Biopharma, Inc. revenue and earnings and make informed decisions.
According to analysts, CUE price target is 3.60 USD with a max estimate of 6.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Cue Biopharma, Inc. stock price chart and keep track of the current situation with CUE news and stock market news.
We've gathered opinions of 5 analysts rating CUE stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.